Q4 2025 Holdings
Filed 2026-02-17 | 68 holdings | $635.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Celcuity Inc(CELC) | COM | 15102K100 | $47.6M | 477,067 | 7.5% |
| The Cigna Group(CI) | COM | 125523100 | $47.4M | 172,203 | 7.5% |
| Sanofi SA(SNY) | SPONSORED ADR | 80105N105 | $47.1M | 971,686 | 7.4% |
| Maximus Inc(MMS) | COM | 577933104 | $43.2M | 500,304 | 6.8% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $34.7M | 385,642 | 5.5% |
| Rhythm Pharmaceuticals Inc(RYTM)Put | COM | 76243J105 | $28.4M | 265,700 | 4.5% |
| Kenvue Inc(KVUE) | COM | 49177J102 | $25.3M | 1,465,442 | 4.0% |
| Organon & Co(OGN) | COMMON STOCK | 68622V106 | $24.5M | 3,421,765 | 3.9% |
| Icon PLC(ICLR) | SHS | G4705A100 | $23.2M | 127,202 | 3.6% |
| Waystar Hldg Corp(WAY) | COM | 946784105 | $20.1M | 613,725 | 3.2% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $19.8M | 322,382 | 3.1% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $19.6M | 474,503 | 3.1% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $14.1M | 1,244,764 | 2.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $14.0M | 201,500 | 2.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $13.8M | 232,688 | 2.2% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $13.8M | 526,002 | 2.2% |
| Brightspring Health Svcs Inc(BTSG) | COM | 10950A106 | $11.5M | 308,010 | 1.8% |
| Centene Corp del(CNC) | COM | 15135B101 | $11.3M | 274,350 | 1.8% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $11.0M | 54,985 | 1.7% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $10.6M | 86,876 | 1.7% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $9.4M | 1,874,641 | 1.5% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $9.1M | 1,715,394 | 1.4% |
| Cross Ctry Healthcare Inc(CCRN) | COM | 227483104 | $8.7M | 1,068,821 | 1.4% |
| Haemonetics Corp Mass(HAE) | COM | 405024100 | $7.4M | 92,631 | 1.2% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $6.9M | 87,272 | 1.1% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $6.4M | 993,095 | 1.0% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $6.4M | 81,883 | 1.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $5.9M | 237,481 | 0.9% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $5.8M | 43,124 | 0.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $5.8M | 124,841 | 0.9% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $5.6M | 185,265 | 0.9% |
| Cencora Inc(COR) | COM | 03073E105 | $5.4M | 15,900 | 0.8% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $5.2M | 6,400 | 0.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $4.6M | 57,586 | 0.7% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $4.4M | 2,164,181 | 0.7% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $4.3M | 382,000 | 0.7% |
| Savara Inc(SVRA) | COM | 805111101 | $3.7M | 613,888 | 0.6% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $3.6M | 118,126 | 0.6% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $3.5M | 387,751 | 0.6% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $3.3M | 2,636,548 | 0.5% |
| Shoulder Innovations Inc(SI) | COMMON STOCK | 82537J108 | $3.3M | 227,971 | 0.5% |
| Aligos Therapeutics Inc(ALGS) | COM NEW | 01626L204 | $3.1M | 335,937 | 0.5% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $2.9M | 478,343 | 0.5% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $2.7M | 95,353 | 0.4% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $2.6M | 75,730 | 0.4% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $2.5M | 32,235 | 0.4% |
| Elicio Therapeutics Inc(ELTX)Put | COM | 28657F103 | $2.4M | 296,900 | 0.4% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $2.3M | 1,427,495 | 0.4% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $2.0M | 1,341,636 | 0.3% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $2.0M | 2,000,000 | 0.3% |